InvestorsHub Logo

ohm20

07/03/19 11:38 AM

#42901 RE: weasel6667 #42838

As I understood Maraviroc seems to be the biggest competitor on CCR5 and as I understood, the only one with good results (but with sever side effects).



The severe side effects put it at a competitive disadvantage to leronlimab.

I assume it will take some more years until a few of those other products will be commercialized and our test could be of use.



Have you never heard of research?